Advertisement

Topics

Curaxis Pharmaceutical Corp Company Profile

10:46 EDT 26th March 2019 | BioPortfolio

Curaxis is an emerging specialty pharmaceutical company with a hormone drug product candidate for the treatment of Alzheimer's disease and multiple cancers. Curaxis' therapeutic platform is based on the hypothesis that many diseases of aging may be caused by age-related changes in the function of the hypothalamic-pituitary-gonadal (HPG) axis. The HPG axis is a hormonal endocrine feedback loop that controls development, reproduction and aging in animals. This drug development platform is built on the premise that hormones associated with this feedback loop are beneficial early in life, when they promote growth and development, but are harmful later in life when the mechanism for feedback is compromised, thereby leading to disease processes, including pathologies associated with Alzheimer's disease and various cancers.


News Articles [359 Associated News Articles listed on BioPortfolio]

Helix BioPharma Corp. Board Changes

RICHMOND HILL, Ontario, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candi...

Emblem Corp. announces new board appointments

TORONTO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) today announced the appointment of Connie A. Stefankiewicz and Loreto Grimaldi ...

RMMI Corp. Completes Initial Public Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS. CA...

International Cannabis Corp. Building Global Network -- CFN Media

SEATTLE, Nov. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, ...

MediPharm Labs Corp. Announces Grant of Stock Options

TORONTO, Oct. 24, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (the “Company” or “MediPharm Labs”) is pleased to announce that the board of directors of the Company has approv...

Helix BioPharma Corp. Closes Second Tranche of Private Placement

RICHMOND HILL, Ontario, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candi...

RMMI Corp. to Commence Trading on the Canadian Securities Exchange

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS. CA...

Helix BioPharma Corp. Closes Third Tranche of Private Placement

RICHMOND HILL, Ontario, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candi...

PubMed Articles [446 Associated PubMed Articles listed on BioPortfolio]

CORP: Partitional Calorimetry.

For thermal physiologists, calorimetry is an important methodological tool to assess human heat balance during heat or cold exposures. A whole-body direct calorimeter remains the gold standard instrum...

IPADAM "Pharmaceutical interventions on the issue of pharmaceutical records and self-medication" quanti survey in 482 French pharmacies.

This study aims to: (i) quantify the number of pharmaceutical interventions (PIs) linked to spontaneous requests for the two oral target molecules, ibuprofen and pseudoephedrine (ii) analyse the cause...

H NMR analytical characterization of mineral oil hydrocarbons (PARAFFINS) for pharmaceutical use.

3D Printing of Pharmaceutical and Medical Applications: a New Era.

The relationship between pharmacy benefit managers (PBMs) and the cost of therapies in the US pharmaceutical market: A policy primer for clinicians.

Pharmaceutical benefit managers (PBMs) are playing an increasingly important role in establishing access to pharmaceutical products for patients. PBMs set retail prices for pharmaceutical products, ne...

Clinical Trials [352 Associated Clinical Trials listed on BioPortfolio]

Clinical Impact of Pharmaceutical Consultations in Patients Treated for Chronic Obstructive Pulmonary Disease at Home

The implementation of pharmaceutical consultations in the city or at the hospital could modify the occurrence of exacerbations related to chronic obstructive pulmonary disease after return...

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Companies [1095 Associated Companies listed on BioPortfolio]

Curaxis Pharmaceutical Corp

Curaxis is an emerging specialty pharmaceutical company with a hormone drug product candidate for the treatment of Alzheimer's disease and multiple cancers. Curaxis' therapeutic platform is based on t...

ATLANTIS DRUG CORP

Nil

NORLOFF COMPUTER CORP

Nil

Precision Engineered Products LLC

SINOCHEM JIANGSU SUZHOU I/E CORP.

SINOCHEM JIANGSU SUZHOU I/E CORP. ESTABLISHED IN 1988, IS A SUBSIDIARY OF SINOCHEM AND A STATE-OWNED FOREIGH TRADE ENTERPRISE AUTHORISED BY THE CHINESE MINISTRY OF FOREIGH TRADE AND ECONOMIC C...

More Information about "Curaxis Pharmaceutical Corp" on BioPortfolio

We have published hundreds of Curaxis Pharmaceutical Corp news stories on BioPortfolio along with dozens of Curaxis Pharmaceutical Corp Clinical Trials and PubMed Articles about Curaxis Pharmaceutical Corp for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Curaxis Pharmaceutical Corp Companies in our database. You can also find out about relevant Curaxis Pharmaceutical Corp Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Endocrinology
Diabetes Diabetes Endocrine Disorders Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several g...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...


Corporate Database Quicklinks



Searches Linking to this Company Record